Year |
Citation |
Score |
2016 |
McHugh RK, Votaw VR, Bogunovic O, Karakula SL, Griffin ML, Weiss RD. Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder. Addictive Behaviors. PMID 27575980 DOI: 10.1016/J.Addbeh.2016.08.020 |
0.311 |
|
2015 |
McHugh RK. Treatment of co-occurring anxiety disorders and substance use disorders. Harvard Review of Psychiatry. 23: 99-111. PMID 25747923 DOI: 10.1097/HRP.0000000000000058 |
0.302 |
|
2014 |
Otto MW, Hearon BA, McHugh RK, Calkins AW, Pratt E, Murray HW, Safren SA, Pollack MH. A randomized, controlled trial of the efficacy of an interoceptive exposure-based CBT for treatment-refractory outpatients with opioid dependence. Journal of Psychoactive Drugs. 46: 402-11. PMID 25364993 DOI: 10.1080/02791072.2014.960110 |
0.723 |
|
2014 |
McHugh RK, Kertz SJ, Weiss RB, Baskin-Sommers AR, Hearon BA, Björgvinsson T. Changes in distress intolerance and treatment outcome in a partial hospital setting. Behavior Therapy. 45: 232-40. PMID 24491198 DOI: 10.1016/J.Beth.2013.11.002 |
0.684 |
|
2013 |
McHugh RK, Reynolds EK, Leyro TM, Otto MW. An Examination of the Association of Distress Intolerance and Emotion Regulation with Avoidance. Cognitive Therapy and Research. 37: 363-367. PMID 32773909 DOI: 10.1007/s10608-012-9463-6 |
0.456 |
|
2013 |
McHugh RK, Whitton SW, Peckham AD, Welge JA, Otto MW. Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review. The Journal of Clinical Psychiatry. 74: 595-602. PMID 23842011 DOI: 10.4088/Jcp.12R07757 |
0.443 |
|
2013 |
McHugh RK, Murray HW, Hearon BA, Pratt EM, Pollack MH, Safren SA, Otto MW. Predictors of dropout from psychosocial treatment in opioid-dependent outpatients. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 22: 18-22. PMID 23398222 DOI: 10.1111/J.1521-0391.2013.00317.X |
0.704 |
|
2012 |
McHugh RK, Weitzman M, Safren SA, Murray HW, Pollack MH, Otto MW. Sexual HIV risk behaviors in a treatment-refractory opioid-dependent sample. Journal of Psychoactive Drugs. 44: 237-42. PMID 23061323 DOI: 10.1080/02791072.2012.703507 |
0.383 |
|
2012 |
Moshier SJ, McHugh RK, Calkins AW, Hearon BA, Rosellini AJ, Weitzman ML, Otto MW. The role of perceived belongingness to a drug subculture among opioid-dependent patients. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 26: 812-20. PMID 22732052 DOI: 10.1037/A0029107 |
0.685 |
|
2012 |
McHugh RK, Otto MW. Refining the measurement of distress intolerance. Behavior Therapy. 43: 641-51. PMID 22697451 DOI: 10.1016/j.beth.2011.12.001 |
0.439 |
|
2012 |
McHugh RK, Otto MW. Profiles of distress intolerance in a substance-dependent sample. The American Journal of Drug and Alcohol Abuse. 38: 161-5. PMID 22185368 DOI: 10.3109/00952990.2011.643990 |
0.444 |
|
2011 |
McHugh RK, Daughters SB, Lejuez CW, Murray HW, Hearon BA, Gorka SM, Otto MW. Shared Variance among Self-Report and Behavioral Measures of Distress Intolerance. Cognitive Therapy and Research. 35: 266-275. PMID 23894216 DOI: 10.1007/S10608-010-9295-1 |
0.709 |
|
2011 |
McHugh RK, Otto MW. Domain-general and domain-specific strategies for the assessment of distress intolerance. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 25: 745-9. PMID 21823763 DOI: 10.1037/a0025094 |
0.422 |
|
2011 |
Weitzman ML, McHugh RK, Otto MW. The association between affect amplification and urgency. Depression and Anxiety. 28: 1105-10. PMID 21681865 DOI: 10.1002/da.20830 |
0.435 |
|
2011 |
McHugh RK, Rasmussen JL, Otto MW. Comprehension of self-report evidence-based measures of anxiety. Depression and Anxiety. 28: 607-14. PMID 21618668 DOI: 10.1002/da.20827 |
0.408 |
|
2011 |
McHugh RK, Hearon BA, Halperin DM, Otto MW. A novel method for assessing distress intolerance: adaptation of a measure of willingness to pay. Journal of Behavior Therapy and Experimental Psychiatry. 42: 440-6. PMID 21570933 DOI: 10.1016/J.Jbtep.2011.04.003 |
0.693 |
|
2011 |
Hearon BA, Calkins AW, Halperin DM, McHugh RK, Murray HW, Otto MW. Anxiety sensitivity and illicit sedative use among opiate-dependent women and men. The American Journal of Drug and Alcohol Abuse. 37: 43-7. PMID 21090958 DOI: 10.3109/00952990.2010.535581 |
0.7 |
|
2010 |
Otto MW, McHugh RK, Kantak KM. Combined Pharmacotherapy and Cognitive-Behavioral Therapy for Anxiety Disorders: Medication Effects, Glucocorticoids, and Attenuated Treatment Outcomes. Clinical Psychology : a Publication of the Division of Clinical Psychology of the American Psychological Association. 17: 91-103. PMID 26855480 DOI: 10.1111/j.1468-2850.2010.01198.x |
0.517 |
|
2010 |
Peckham AD, McHugh RK, Otto MW. A meta-analysis of the magnitude of biased attention in depression. Depression and Anxiety. 27: 1135-42. PMID 21049527 DOI: 10.1002/Da.20755 |
0.365 |
|
2010 |
McHugh RK, Murray HW, Hearon BA, Calkins AW, Otto MW. Attentional bias and craving in smokers: the impact of a single attentional training session. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 12: 1261-4. PMID 20961974 DOI: 10.1093/Ntr/Ntq171 |
0.665 |
|
2010 |
McHugh RK, Hearon BA, Otto MW. Cognitive behavioral therapy for substance use disorders. The Psychiatric Clinics of North America. 33: 511-25. PMID 20599130 DOI: 10.1016/J.Psc.2010.04.012 |
0.72 |
|
2010 |
Otto MW, McHugh RK, Simon NM, Farach FJ, Worthington JJ, Pollack MH. Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation. Behaviour Research and Therapy. 48: 720-7. PMID 20546699 DOI: 10.1016/J.Brat.2010.04.002 |
0.483 |
|
2010 |
Murray HW, McHugh RK, Rowley TC, Sirota AD, Otto MW. Development and validation of the smoking cue appeal survey. Substance Use & Misuse. 45: 2152-61. PMID 20469971 DOI: 10.3109/10826084.2010.481771 |
0.358 |
|
2010 |
Ocañez KL, McHugh RK, Otto MW. A meta-analytic review of the association between anxiety sensitivity and pain. Depression and Anxiety. 27: 760-7. PMID 20336798 DOI: 10.1002/da.20681 |
0.341 |
|
2010 |
Behar E, McHugh RK, Peckham A, Otto MW. D-cycloserine for the augmentation of an attentional training intervention for trait anxiety. Journal of Anxiety Disorders. 24: 440-5. PMID 20236791 DOI: 10.1016/J.Janxdis.2010.02.009 |
0.445 |
|
2010 |
McHugh RK, Behar E, Gutner CA, Geem D, Otto MW. Cortisol, stress, and attentional bias toward threat. Anxiety, Stress, and Coping. 23: 529-45. PMID 20191400 DOI: 10.1080/10615801003596969 |
0.372 |
|
2010 |
McHugh RK, Hofmann SG, Asnaani A, Sawyer AT, Otto MW. The serotonin transporter gene and risk for alcohol dependence: a meta-analytic review. Drug and Alcohol Dependence. 108: 1-6. PMID 20060655 DOI: 10.1016/J.Drugalcdep.2009.11.017 |
0.351 |
|
2010 |
Behar E, McHugh RK, Otto MW. Elucidating the Relationship between Worry and Physical Health Journal of Experimental Psychopathology. 1: jep.008210. DOI: 10.5127/Jep.008210 |
0.373 |
|
2009 |
McHugh RK, Smits JA, Otto MW. Empirically supported treatments for panic disorder. The Psychiatric Clinics of North America. 32: 593-610. PMID 19716992 DOI: 10.1016/j.psc.2009.05.005 |
0.489 |
|
2009 |
Otto MW, Basden SL, McHugh RK, Kantak KM, Deckersbach T, Cather C, Goff DC, Hofmann SG, Berry AC, Smits JA. Effects of D-cycloserine administration on weekly nonemotional memory tasks in healthy participants. Psychotherapy and Psychosomatics. 78: 49-54. PMID 19018157 DOI: 10.1159/000172620 |
0.701 |
|
2008 |
Murray H, McHugh RK, Behar E, Pratt E, Otto M. Personality factors associated with methadone maintenance dose. The American Journal of Drug and Alcohol Abuse. 34: 634-41. PMID 18821457 DOI: 10.1080/00952990802308163 |
0.405 |
|
2007 |
McHugh RK, Otto MW, Barlow DH, Gorman JM, Shear MK, Woods SW. Cost-efficacy of individual and combined treatments for panic disorder. The Journal of Clinical Psychiatry. 68: 1038-44. PMID 17685740 DOI: 10.4088/Jcp.V68N0710 |
0.423 |
|
2007 |
Otto MW, Basden SL, Leyro TM, McHugh RK, Hofmann SG. Clinical perspectives on the combination of D-cycloserine and cognitive-behavioral therapy for the treatment of anxiety disorders. Cns Spectrums. 12: 51-6, 59-61. PMID 17192764 DOI: 10.1017/S1092852900020526 |
0.733 |
|
Show low-probability matches. |